{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:12:15Z","timestamp":1775560335067,"version":"3.50.1"},"reference-count":25,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Borderline ovarian tumors often affect women of reproductive age for whom fertility preservation may be a major concern. While fertility-sparing surgery is widely accepted, the safety of controlled ovarian stimulation for oocyte cryopreservation after surgery remains uncertain due to potential recurrence risk. This retrospective single-center cohort study explored the association between controlled ovarian stimulation following fertility-sparing surgery and both recurrence risk and reproductive outcomes. Patients treated between January 2011 and June 2024 were included. Baseline characteristics, surgical details, and reproductive outcomes were compared using non-parametric and exact tests. Progression-free survival was assessed with Kaplan\u2013Meier estimates and Cox proportional hazards models, modeling stimulation as a time-dependent covariate, and using a 10-month landmark analysis to account for immortal time bias. Of 45 included patients, 19 underwent ovarian stimulation after surgery, with a median interval of 9.9 months to stimulation. Median follow-up was 34.4 months. Recurrence occurred in 21.1% of stimulated patients versus 38.5% of non-stimulated patients (p = 0.338). After adjustment for time-dependent exposure, ovarian stimulation was not associated with increased recurrence risk (HR 0.95, 95% CI 0.22\u20134.09; p = 0.944). Eleven patients (24.4%) achieved at least one pregnancy, 81.8% of which were spontaneous. Controlled ovarian stimulation for oocyte cryopreservation after fertility-sparing surgery for borderline ovarian tumors did not show an increased recurrence risk, although larger studies are needed.<\/jats:p>","DOI":"10.3390\/curroncol33040206","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:12:33Z","timestamp":1775437953000},"page":"206","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Controlled Ovarian Stimulation After Fertility-Sparing Surgery for Borderline Ovarian Tumors: An Exploratory Cohort Study on Recurrence and Reproductive Outcomes"],"prefix":"10.3390","volume":"33","author":[{"given":"Sofia","family":"Thiella","sequence":"first","affiliation":[{"name":"Centre for Research and Studies on Reproductive Health, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8319-6146","authenticated-orcid":false,"given":"Giacomo","family":"Corrado","sequence":"additional","affiliation":[{"name":"Gynaecologic Oncology Unit, Department of Woman\u2019s and Child Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4501-3038","authenticated-orcid":false,"given":"Paola","family":"Villa","sequence":"additional","affiliation":[{"name":"Gynaecologic Oncology Unit, Department of Woman\u2019s and Child Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"},{"name":"Department of Life Sciences and Public Health Section of Hygiene, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"},{"name":"Department of Woman\u2019s and Child Health and Public Health Sciences, Quality of Life, Integrated Therapies and Oncology Follow-Up, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, 00167 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8665-9487","authenticated-orcid":false,"given":"Inge","family":"Peters","sequence":"additional","affiliation":[{"name":"Gynaecologic Oncology Unit, Department of Woman\u2019s and Child Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Giannarelli","sequence":"additional","affiliation":[{"name":"Epidemiology and Biostatistics Research Core Facility Gemelli Science and Technology Park (G-STeP), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6448-6279","authenticated-orcid":false,"given":"Rossella Letizia","family":"Mancusi","sequence":"additional","affiliation":[{"name":"Epidemiology and Biostatistics Research Core Facility Gemelli Science and Technology Park (G-STeP), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2959-8571","authenticated-orcid":false,"given":"Tina","family":"Pasciuto","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Public Health Section of Hygiene, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"},{"name":"Data Collection Research Core Facility Gemelli Science and Technology Park (G-SteP), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3864-6883","authenticated-orcid":false,"given":"Lucrezia","family":"Massaro","sequence":"additional","affiliation":[{"name":"Centre for Research and Studies on Reproductive Health, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3893-8788","authenticated-orcid":false,"given":"Maria Luisa","family":"Di Pietro","sequence":"additional","affiliation":[{"name":"Centre for Research and Studies on Reproductive Health, Catholic University of the Sacred Heart, 00168 Rome, Italy"},{"name":"Department of Life Sciences and Public Health Section of Hygiene, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3859-4591","authenticated-orcid":false,"given":"Maria Lucia","family":"Specchia","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Public Health Section of Hygiene, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-335X","authenticated-orcid":false,"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[{"name":"Gynaecologic Oncology Unit, Department of Woman\u2019s and Child Health and Public Health Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00167 Rome, Italy"},{"name":"Faculty of Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1634\/theoncologist.2012-0139","article-title":"Diagnosis, treatment, and follow-up of borderline ovarian tumors","volume":"17","author":"Fischerova","year":"2012","journal-title":"Oncologist"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Pecorino, B., Lagan\u00e0, A.S., Mereu, L., Ferrara, M., Carrara, G., Etrusco, A., Murgia, F., De Iaco, P., Caruso, A., and Candiani, M. (2023). Evaluation of borderline ovarian tumor recurrence rate after surgery with or without fertility-sparing approach: Results of a retrospective analysis. Healthcare, 11.","DOI":"10.3390\/healthcare11131922"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Drymiotou, S., Theodorou, E., Rallis, K.S., Nicolaides, M., and Sideris, M. (2025). Molecular biomarkers in borderline ovarian tumors: Towards personalized treatment and prognostic assessment. Cancers, 17.","DOI":"10.3390\/cancers17030545"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1016\/S1470-2045(24)00262-6","article-title":"Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: Guidelines from ESGO, ESHRE, and ESGE","volume":"25","author":"Morice","year":"2024","journal-title":"Lancet Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Niu, L., Tian, H., Xu, Y., Cao, J., Zhang, X., Zhang, J., Li, H., Sun, Q., Wang, Y., and Liu, Y. (2021). Recurrence characteristics and clinicopathological results of borderline ovarian tumors. BMC Womens Health, 21.","DOI":"10.1186\/s12905-021-01263-y"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"101961","DOI":"10.1016\/j.jogoh.2020.101961","article-title":"Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group","volume":"50","author":"Sangnier","year":"2021","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.7150\/jca.56387","article-title":"Analysis of factors influencing relapse and pregnancy in patients with borderline ovarian tumors","volume":"12","author":"Qi","year":"2021","journal-title":"J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101965","DOI":"10.1016\/j.jogoh.2020.101965","article-title":"Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers","volume":"50","author":"Huchon","year":"2021","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5468\/ogs.2017.60.3.289","article-title":"Oncologic and obstetric outcomes of conservative surgery for borderline ovarian tumors in women of reproductive age","volume":"60","author":"Lee","year":"2017","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ejso.2019.11.001","article-title":"Fertility-sparing surgery in borderline ovarian tumour patients and pregnancy outcome","volume":"46","author":"Candotti","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.fertnstert.2024.09.023","article-title":"An umbrella review of meta-analyses regarding the incidence of female-specific malignancies after fertility treatment","volume":"123","author":"Saso","year":"2025","journal-title":"Fertil. Steril."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/djaa163","article-title":"Long-term risk of ovarian cancer and borderline tumors after assisted reproductive technology","volume":"113","author":"Spaan","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/humrep\/deaa293","article-title":"Fertility treatment and cancers\u2014The eternal conundrum: A systematic review and meta-analysis","volume":"36","author":"Barcroft","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00404-023-07103-8","article-title":"Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?","volume":"309","author":"Gao","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ygyno.2021.03.030","article-title":"Fertility preservation in women with malignant and borderline ovarian tumors: Experience of the French ESGO-certified center\u2014A pregnancy-associated cancer network (CALG)","volume":"161","author":"Geoffron","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ygyno.2021.03.023","article-title":"Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors: An analysis from the MITO14 study database","volume":"161","author":"Falcone","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The STROBE statement: Guidelines for reporting observational studies","volume":"18","author":"Altman","year":"2007","journal-title":"Epidemiology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13048-025-01819-8","article-title":"Tumor recurrence risk following different COS regimens in infertile women with borderline ovarian tumors: Impact on IVF outcomes","volume":"18","author":"Liang","year":"2025","journal-title":"J. Ovarian Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Canlorbe, G., Chabbert-Buffet, N., and Uzan, C. (2021). Fertility-sparing surgery for ovarian cancer. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184235"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/humrep\/deq159","article-title":"Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: An 11-year follow-up","volume":"25","author":"Palomba","year":"2010","journal-title":"Hum. Reprod."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1007\/s00404-024-07445-x","article-title":"Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumors","volume":"309","author":"Cosyns","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10815-025-03522-5","article-title":"Fertility preservation through oocyte or embryo vitrification prior to oncological treatment: A 12-year experience","volume":"42","author":"Zimmermann","year":"2025","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Porcu, E., Cipriani, L., Dirodi, M., De Iaco, P., Perrone, A.M., Zinzani, P.L., Nannini, M., Galli, F., Cosio, S., and Rossi, C. (2022). Successful pregnancies, births, and child development following oocyte cryostorage in female cancer patients during 25 years of fertility preservation. Cancers, 14.","DOI":"10.3390\/cancers14061429"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"17789","DOI":"10.1038\/s41598-023-44055-0","article-title":"A Markov-model simulation of IVF programs for PCOS patients indicates that coupling myo-inositol with rFSH is cost-effective for the Italian Health System","volume":"13","author":"Beresniak","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_25","unstructured":"European Observatory on Health Systems and Policies (2023). Regulation\u2014Italy Health System Review 2023, WHO Regional Office for Europe. Available online: https:\/\/eurohealthobservatory.who.int\/monitors\/."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/4\/206\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T10:30:38Z","timestamp":1775557838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/4\/206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["curroncol33040206"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33040206","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]}}}